Vaccination in Liver Transplant Candidates and Recipients: Current Challenges and Emerging Strategies - 16/11/26
, Giulia Camillieri 1, 2, ⁎, Lolita Sasset 3, Chiara Suraci 2, 4, Francesco Paolo Russo 2, 4, Alberto Zanetto 2, 4, Giacomo Germani 1, 2, Pierluigi Toniutto 5, Paolo Antonio Grossi 6, Annamaria Cattelan 3, Patrizia Burra 2, 4Highlights |
• | Vaccination should begin early in chronic liver disease, particularly before LT in order to complete the schedule before surgery. |
• | Immunosuppression limits vaccine responses and influences the post-LT timing. |
• | Live vaccines are avoided after adult LT but may be used in selected populations like at-risk children. |
• | Structured pathways and tailored strategies may improve vaccine protection. |
ABSTRACT |
Patients with liver cirrhosis, particularly those with advanced disease, are at increased risk of bacterial and viral infections, which may in turn trigger further hepatic decompensation. Similarly, infections remain a major cause of hospitalization and morbidity after liver transplantation. Many of these infections can be actively prevented through systematic vaccination programs implemented both before and after transplantation. In the pre-transplant setting, the main challenges include reduced vaccine immunogenicity related to cirrhosis-associated immune dysfunction, frailty, and comorbidities commonly observed in patients with end-stage liver disease. After liver transplantation, vaccine-induced protection may be further limited by reduced immunogenicity compared with the general population and, at least in adult recipients, by the contraindication to live attenuated vaccines. Conversely, available evidence does not support an association between vaccination and the development of post-transplant immune-mediated complications. Practical strategies to improve protection include structured pre- and post-transplant vaccination pathways, targeted serological assessment, household vaccination, electronic reminders, individualized schedules for patients at high risk of non-response, tailored counseling, and measures to address barriers to vaccine access. Integrating vaccination into multidisciplinary transplant care may reduce preventable infectious morbidity in this vulnerable population. This narrative review summarizes practical recommendations across the liver transplant pathway, distinguishes standard of care from emerging evidence and investigational approaches, and discusses strategies to improve immunogenicity and equitable vaccine uptake.
Le texte complet de cet article est disponible en PDF.Keywords : liver transplantation, vaccination, cirrhosis, immunosuppression, vaccine-preventable infections, transplant infectious diseases
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
